Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: A randomized, double-blind, placebo-controlled phase III study

1. Swain, S.M.
2. Ewer, M.S.
3. Cortés, J.
4. Amadori, D.
5. Miles, D.
6. Knott, A.
7. Clark, E.
8. Benyunes, M.C.
9. Ross, G.
10. Baselga, J.